"たけだP" の関連情報検索結果

Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide ...



Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera  Business Wire

Earnings Tell The Story For Takeda Pharmaceutical Company Limited (TSE:4502) - simplywall.st



Earnings Tell The Story For Takeda Pharmaceutical Company Limited (TSE:4502)  simplywall.st

Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti - koreabi...



Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti  koreabiomed.com

Korean drug Kecap advances toward U.S. approval, challenging Takeda's Boeqezna - CHOSUNBIZ - Chos...



Korean drug Kecap advances toward U.S. approval, challenging Takeda's Boeqezna - CHOSUNBIZ  Chosunbiz

Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures - BioSpace



Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures  BioSpace

Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlest...



Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat  GlobeNewswire

Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle - korea...



Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle  koreabiomed.com

Zydus Licenses Takeda's GERD Drug Vonoprazan for India - Rediff MoneyWiz



Zydus Licenses Takeda's GERD Drug Vonoprazan for India  Rediff MoneyWiz

Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndro...



Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome  Business Wire

Zydus ties with Takeda to sell GERD drug - Mint



Zydus ties with Takeda to sell GERD drug  Mint

Torrent Pharma, Takeda to commercialise GI drug in India - Times of India



Torrent Pharma, Takeda to commercialise GI drug in India  Times of India

Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India - Business Standard



Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India  Business Standard

Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? - Yahoo Finance



Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?  Yahoo Finance

Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on t...



Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf  Fierce Biotech

Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company - koreabiome...



Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company  koreabiomed.com

Torrent Pharma in pact with Takeda to commercialize acid reflux drug - Mint



Torrent Pharma in pact with Takeda to commercialize acid reflux drug  Mint

Torrent Pharma Licenses Vonoprazan GERD Drug from Takeda - Rediff MoneyWiz



Torrent Pharma Licenses Vonoprazan GERD Drug from Takeda  Rediff MoneyWiz

Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data - Fi...



Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data  Fierce Biotech

Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dre...



Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dream  Fierce Biotech

Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data d...



Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail  Fierce Biotech

Neurocrine’s Takeda-Partnered Drug Candidate Aces Phase II Depression Study - BioSpace



Neurocrine’s Takeda-Partnered Drug Candidate Aces Phase II Depression Study  BioSpace

Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in ...



Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in India  Express Pharma

Lymphocytopenia following adjuvant radiotherapy for breast cancer - Takeda - 2024 - Precision Rad...



Lymphocytopenia following adjuvant radiotherapy for breast cancer - Takeda - 2024 - Precision Radiation Oncology  Wiley Online Library

Takeda's Oncology Chief Joins Lantheus Board: Major Win for Radiopharmaceutical Pipeline - Stock ...



Takeda's Oncology Chief Joins Lantheus Board: Major Win for Radiopharmaceutical Pipeline  Stock Titan

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? - Nasdaq



Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?  Nasdaq

Recon: Takeda CEO Weber to step down; Merck halts PAH drug trial early on strong efficacy data - ...



Recon: Takeda CEO Weber to step down; Merck halts PAH drug trial early on strong efficacy data  Regulatory Affairs Professionals Society | RAPS

Impact of raising the upper extremity siding cardiac implantable electrical devices on postoperat...



Impact of raising the upper extremity siding cardiac implantable electrical devices on postoperative safety  Wiley Online Library

How This Takeda Technology Exec Is Embracing The Possibilities 04/24/2025 - MediaPost



How This Takeda Technology Exec Is Embracing The Possibilities 04/24/2025  MediaPost

Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another - BioSpace



Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another  BioSpace

Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now? - Yahoo



Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now?  Yahoo

Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris - The Motley Fool



Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris  The Motley Fool

A Six-Year-Old with a Rare Disease Finds Answers – and Treatment - Direct Relief



A Six-Year-Old with a Rare Disease Finds Answers – and Treatment  Direct Relief

Poseida’s $6B blood relationship with Roche akin to Takeda deal in concept, strategy: CEO - BioWo...



Poseida’s $6B blood relationship with Roche akin to Takeda deal in concept, strategy: CEO  BioWorld MedTech

FANUC COBOT EASES PAIN FOR TAKEDA PHARMACEUTICAL CO - Process and Control Today



FANUC COBOT EASES PAIN FOR TAKEDA PHARMACEUTICAL CO  Process and Control Today

Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets - GlobeNewswire



Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets  GlobeNewswire

Cipla signs agreement with Takeda to commercialise Vonoprazan - Express Pharma



Cipla signs agreement with Takeda to commercialise Vonoprazan  Express Pharma

Takeda-Amgen treatment improves survival in metastatic colorectal cancer - BioWorld MedTech



Takeda-Amgen treatment improves survival in metastatic colorectal cancer  BioWorld MedTech

Transition‐Metal‐Free Cross‐Coupling by Using Tertiary Benzylic Organoboronates - Wiley Online Li...



Transition‐Metal‐Free Cross‐Coupling by Using Tertiary Benzylic Organoboronates  Wiley Online Library

Best Value Stocks to Buy for April 30th - TradingView



Best Value Stocks to Buy for April 30th  TradingView

Figure 1. Functional role of Takeda G-protein-coupled receptor 5 (TGR5)... - ResearchGate



Figure 1. Functional role of Takeda G-protein-coupled receptor 5 (TGR5)...  ResearchGate

Jumping Crystal of a Hydrogen-Bonded Organic Framework Induced by the Collective Molecular Motion...



Jumping Crystal of a Hydrogen-Bonded Organic Framework Induced by the Collective Molecular Motion of a Twisted π System  Wiley Online Library

Takeda gives Sun Pharma, Cipla rights to commercialise gastro drug in India - ET Manufacturing



Takeda gives Sun Pharma, Cipla rights to commercialise gastro drug in India  ET Manufacturing

Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Per...



Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn’s Disease Patients with Cx601  Business Wire

Dibenzo[a,j]phenazine‐Cored Donor–Acceptor–Donor Compounds as Green‐to‐Red/NIR Thermally Activate...



Dibenzo[a,j]phenazine‐Cored Donor–Acceptor–Donor Compounds as Green‐to‐Red/NIR Thermally Activated Delayed Fluorescence Organic Light Emitters - Data - 2016 - Angewandte Chemie International Edition  Wiley Online Library

Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Can...



Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College, and Partnership Formed with Takeda  WCM Newsroom

Entyvio by Takeda Pharmaceuticals - Pharmacy Times



Entyvio by Takeda Pharmaceuticals  Pharmacy Times

Takeda, Frazier Healthcare Partners to launch Phathom Pharma - BioSpectrum Asia



Takeda, Frazier Healthcare Partners to launch Phathom Pharma  BioSpectrum Asia

Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India - ET HealthWorld



Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India  ET HealthWorld

Loss and Gain: Surviving the 2011 Tohoku Tsunami - commons.trincoll.edu



Loss and Gain: Surviving the 2011 Tohoku Tsunami  commons.trincoll.edu

Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in Ind...



Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India  Express Pharma

Mankind Pharma inks pact with Takeda to commercialise acidity drug in India - Business Standard



Mankind Pharma inks pact with Takeda to commercialise acidity drug in India  Business Standard

Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in Indi...



Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India  The Financial Express

TAKECAB® Now Available for the Treatment of Acid-related Diseases in Japan - otsuka.co.jp



TAKECAB® Now Available for the Treatment of Acid-related Diseases in Japan  otsuka.co.jp